Goldman Sachs Sees High Merger Odds For This Large-Cap Biopharma In Trump 2.0 Era: Retail Has Been Alert
First Published Jan 17, 2025, 1:00 AM IST | Last Updated Jan 17, 2025, 1:00 AM IST Goldman Sachs has flagged Insmed Inc. as a potential merger candidate under the pro-business policies of the incoming Donald Trump administration, CNBC reported. The …